Aβ Plaques.

Area of Science:

• Neuropathology
• Neurodegenerative Diseases
• Alzheimer's Disease Pathogenesis

Background:

• Amyloid-beta (Aβ) plaques are a defining neuropathological hallmark of Alzheimer's disease (AD).
• These plaques are heterogeneous, comprising Aβ-amyloid and sometimes cellular elements, and have been historically termed senile or neuritic plaques.
• While Aβ plaques are universal, tauopathy is critical for dementia manifestation, with the link between Aβ and tau pathology remaining unclear.

Purpose of the Study:

• To elucidate the nature and pathogenic role of Aβ plaques in Alzheimer's disease.
• To explore the mechanisms of Aβ plaque formation and propagation.
• To discuss the therapeutic implications of targeting Aβ plaques and related species.

Main Methods:

• Review and synthesis of existing literature on Aβ plaque structure, formation, and role in AD.
• Analysis of the relationship between Aβ plaques, tauopathy, and dementia.
• Evaluation of potential therapeutic strategies targeting Aβ aggregation.

Main Results:

• Aβ plaques develop and spread through a prion-like mechanism of seeded protein aggregation.
• Small, soluble Aβ oligomers near plaques are likely major contributors to neurotoxicity.
• Risk factors for plaques and AD include inflammation, genetics, and environmental triggers, but no single cause is identified.

Conclusions:

• Aβ plaques are central to AD pathogenesis, developing over long timecourses.
• Therapies targeting Aβ production or aggregation are most effective when initiated early.
• Understanding Aβ plaques is crucial for developing effective Alzheimer's disease treatments.